Exclusive

Publication

Byline

China's Brii Biosciences announces new agreement to address global antimicrobial resistance threats

Singapore, July 4 -- Brii Biosciences Limited, a biotechnology company developing therapies to improve patient health and choice across diseases with high unmet medical needs,has entered into a licens... Read More


Korea to develop AI-based diagnostic reagents for high-risk pathogens

Singapore, July 3 -- Attoplex Inc., a South Korea-based startup specialising in in vitro diagnostic (IVD) medical devices, has signed a Memorandum of Understanding (MoU) with ProfessorMinsu Kim'sresea... Read More


Lunit and Microsoft collaborate to advance AI-driven cancer diagnosis

Singapore, July 3 -- South Korea-based Lunit, a leading provider of artificial intelligence (AI) for cancer diagnostics and therapeutics, has announced a collaboration with Microsoft to accelerate the... Read More


AN Venture Partners announces one of the largest Japan focused biotech funds to date

Singapore, July 3 -- AN Venture Partners (ANV), a global biotech venture capital firm, has announced the final close of its first fund, AN Venture Partners I, LP, achieving its target of $200 million ... Read More


PHC announces exclusive distribution of MaxCyte ExPERT platform in Japan

Singapore, July 2 -- The Biomedical Division of Japan-based PHC Corporation (PHCbi), a subsidiary of PHC Holdings Corporation (PHCHD), has signed an exclusive agreement with MaxCyte, Inc. to distribut... Read More


Indian biopharma firm Biological E partners with China's Recbio to produce HPV9 vaccine

Singapore, July 2 -- Jiangsu Recbio Technology, a leading Chinese biopharmaceutical company, has entered into a licensing cooperation agreement, and have commenced the technology transfer of their Rec... Read More


WuXi XDC accelerates global expansion of bioconjugates manufacturing by revitalising Singapore site

Singapore, July 2 -- WuXi XDC Cayman Inc. a leading global Contract Research, Development and Manufacturing Organisation (CRDMO) focused on the bioconjugate industry, has announced that the mechanical... Read More


Korea's Seegene launches STAgora, new platform for infectious disease analytics

Singapore, July 2 -- South Korea-based Seegene Inc., a global leader in molecular diagnostics (MDx) solutions, has announced the launch of STAgora, a next-generation platform for infectious disease an... Read More


China's WuXi Biologics launches next-generation platform for high-concentration biologics

Singapore, July 1 -- WuXi Biologics, a leading global Contract Research, Development, and Manufacturing Organisation (CRDMO) in China, has announced the launch of WuXiHigh 2.0, a high-throughput formu... Read More


ETT and Fujifilm extend access to innovative treatments for obesity in Middle East

Singapore, July 1 -- Endo Tools Therapeutics (ETT),a Belgium-based company developing and marketing advanced endoscopic medical devices, and Fujifilm Middle East FZE, a subsidiary of Fujifilm Holdings... Read More